# Oral Anticoagulation in Patients With Prior Deep Intracerebral Hemorrhage, Atrial Fibrillation, and Ischemic Stroke

Study · id `cardio:ct-nct07609654` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07609654](<https://clinicaltrials.gov/study/NCT07609654>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07609654

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 852 participants.

## Technical summary

Registry record NCT07609654. Randomized; single masking; primary purpose treatment. Start 2026-10-26 (anticipated); primary completion 2031-11-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 852 participants (planned count; ClinicalTrials.gov record NCT07609654, source copy `cardio:ctgov-nct07609654-2026-10-20`, retrieved 2026-10-26)
- Planned start: 2026-10-26 (anticipated) (ClinicalTrials.gov record NCT07609654, source copy `cardio:ctgov-nct07609654-2026-10-20`, retrieved 2026-10-26)
- Primary completion: 2031-11-01 (anticipated) (ClinicalTrials.gov record NCT07609654, source copy `cardio:ctgov-nct07609654-2026-10-20`, retrieved 2026-10-26)
- Completion: 2032-02-01 (anticipated) (ClinicalTrials.gov record NCT07609654, source copy `cardio:ctgov-nct07609654-2026-10-20`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07609654, source copy `cardio:ctgov-nct07609654-2026-10-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07609654-2026-10-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Oral Anticoagulation in Patients With Prior Deep Intracerebral Hemorrhage, Atrial Fibrillation, and Ischemic Stroke
- Acronym: OASIS-AF
- Condition: Intracerebral Hemorrhage
- Condition: Atrial Fibrillation (AF)
- Condition: Ischemia Stroke
- Intervention (Drug): Apixaban
- Intervention (Other): No Oral Anticoagulation Strategy
- Lead sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Bleeding in the brain (intracerebral hemorrhage) (`cardio:intracerebral-hemorrhage`)
- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Apixaban (`cardio:apixaban`)
- Registry lists this organization as the lead sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine (`cardio:org-second-affiliated-hospital-zhejiang-university-school-of-bfd3ac`)

## Provenance

Content hash: 45bac8d245f138d5a7bd439613264fe8942f51087df73278e408709ded9db28b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
